micafungin

Poland

Drugs containing this active substance

  • MICAFUNGIN ACCORD

    The medicine is used to treat fungal infections caused by Candida yeast. It may be used to treat severe infections in adults and children, to treat esophageal infections, and to prevent infections in patients undergoing stem cell transplants or in individuals at risk of neutropenia.

    Form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    micafungin 50 mg

    ATC: J02AX05

    Manufacturer: Accord Healthcare Polska Sp. z o.o.

  • The medicinal product is used to treat fungal infections caused by Candida yeast. It may be used to treat severe infections in adults and children, to treat esophageal infections, and to prevent infections in patients undergoing stem cell transplants or in individuals at risk of developing neutropenia.

    Form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    micafungin 100 mg

    ATC: J02AX05

    Manufacturer: Accord Healthcare Polska Sp. z o.o.

  • The medicinal product is used to treat fungal infections caused by yeasts of the Candida genus. It may be used to treat severe systemic infections in adults, adolescents, and children, to treat esophageal infections, and for the prevention of infections in patients undergoing stem cell transplants or in individuals at risk of developing neutropenia.

    Form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    micafungin 50 mg

    ATC: J02AX05

    Manufacturer: Accord Healthcare Polska Sp. z o.o.

  • The medicinal product is used to treat fungal infections caused by yeasts of the Candida genus. It may be used in the treatment of invasive candidiasis in adults, adolescents, and children (including neonates), in the treatment of esophageal infection in adults and adolescents (over 16 years of age), and in the prevention of infections in patients undergoing stem cell transplants or in individuals at risk of developing neutropenia.

    Form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    micafungin 100 mg

    ATC: J02AX05

    Manufacturer: Accord Healthcare Polska Sp. z o.o.

  • This is an antifungal medicine used to treat infections caused by fungi or yeasts of the Candida group. It is used to treat systemic (internal) infections, esophageal infections, and for the prevention of infections in patients undergoing stem cell transplants or in individuals at risk of developing neutropenia.

    Form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    micafungin 50 mg

    ATC: J02AX05

    Manufacturer: Rompharm Company S.R.L.

  • This is an antifungal medicine used to treat infections caused by fungi or yeasts from the Candida group. It is used in the treatment of invasive candidiasis (generalized infection), esophageal infections, and for the prevention of infections in patients undergoing stem cell transplants or in individuals at risk of developing neutropenia.

    Form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    micafungin 100 mg

    ATC: J02AX05

    Manufacturer: Rompharm Company S.R.L.

  • The medicine is used to treat fungal infections caused by yeasts of the Candida group. It may be used to treat severe systemic infections in adults, adolescents, and children (including neonates), to treat esophageal infections in persons over 16 years of age, and to prevent infections in patients undergoing stem cell transplants or in individuals at risk of developing neutropenia.

    Form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    micafungin 100 mg

    ATC: J02AX05

    Manufacturer: S.C. Rompharm Company S.R.L.

  • This is an antifungal medicine used to treat infections caused by fungi or yeasts of the Candida genus. It is used in the treatment of systemic infections, esophageal infections, and in the prevention of infections in patients undergoing stem cell transplants or in individuals at risk of neutropenia.

    Form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    micafungin 50 mg

    ATC: J02AX05

    Manufacturer: S.C. Rompharm Company S.R.L.

  • The medicine is used to treat fungal infections caused by Candida yeast. It may be used to treat severe infections in adults and children, to treat esophageal infections, and to prevent infections in patients undergoing stem cell transplants or in individuals at risk of neutropenia.

    Form: solution for infusion, powder for preparation of

    Active substance Dosage
    micafungin 50 mg

    ATC: J02AX05

    Manufacturer: BAG Health Care GmbH Galenicum Health, S.L. Lek Pharmaceuticals d.d. SAG Manufacturing S.L.U.

  • The medicine is used to treat fungal infections caused by Candida yeast. It may be used to treat severe infections in adults and children, to treat esophageal infections, and to prevent infections in patients undergoing stem cell transplants or in individuals at risk of neutropenia.

    Form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    micafungin 100 mg

    ATC: J02AX05

    Manufacturer: BAG Health Care GmbH Galenicum Health, S.L. Lek Pharmaceuticals d.d. SAG Manufacturing S.L.U.

  • The medicinal product is used to treat fungal infections caused by yeasts of the Candida group. It may be used to treat severe infections in adults, adolescents, and children (including neonates), to treat esophageal infections in persons over 16 years of age, and to prevent infections in patients undergoing stem cell transplants or in individuals at risk of developing neutropenia.

    Form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    micafungin 50.86 mg

    ATC: J02AX05

    Manufacturer: Merckle GmbH S.C. Sindan-Pharma S.R.L.

  • The medicinal product is used to treat fungal infections caused by yeasts of the Candida genus. It may be used to treat severe infections in adults, adolescents, and children (including neonates), to treat esophageal infections in adults and adolescents (over 16 years of age), and to prevent infections in patients undergoing stem cell transplants or in individuals at risk of developing neutropenia.

    Form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    micafungin 100 mg

    ATC: J02AX05

    Manufacturer: Merckle GmbH S.C. Sindan-Pharma S.R.L.

  • The medicinal product is used to treat fungal infections caused by Candida yeast, including systemic infections (affecting the whole body). It is also used for the prevention of infections in patients undergoing stem cell transplants or in individuals at risk of developing neutropenia.

    Form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    micafungin 50 mg

    ATC: J02AX05

    Manufacturer: Laboratori FUNDACIO DAU

  • The medicine is used to treat fungal infections caused by Candida yeast, including systemic infections. It is also used for the prevention of infections in patients undergoing stem cell transplants or in individuals at risk of a decrease in white blood cell count (neutropenia).

    Form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    micafungin 100 mg

    ATC: J02AX05

    Manufacturer: Laboratori FUNDACIO DAU